Evidence map›Paper›PMID 34169223›Full record

ArticleJournal of the Canadian Association of Gastroenterology2020

Development of a Global Rating Scale for Inflammatory Bowel Disease.

Alain Bitton, Katharine S Devitt, Brian Bressler, Joan Heatherington, Vipul Jairath, Jennifer Jones, Paul Moayyedi, Adam V Weizman, Catherine Dubé, Donald MacIntosh and 1 more

Open access · goldAbstract read
In one paragraph

Article in Journal of the Canadian Association of Gastroenterology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.2field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 4 citations in OpenAlex.

  1. The utility of website-based quality improvement tools for health professionals: a systematic review.International journal for quality in health care : journal of the International Society for Quality in Health Care · 2024
    Pooled it
  2. Patient and Public Involvement in Inflammatory Bowel Disease Research-A Scoping Review.Journal of the Canadian Association of Gastroenterology · 2024
    Article
  3. The 2023 Impact of Inflammatory Bowel Disease in Canada: Access to and Models of Care.Journal of the Canadian Association of Gastroenterology · 2023
    Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 9 institutions in 1 country.

Alain BittonDivision of Gastroenterology, McGill University Health Centre, Montreal, Quebec, Canada.
Katharine S DevittDepartment of Research and Patient Programs, Crohn's and Colitis Canada, Toronto, Ontario, Canada.
Brian BresslerDivision of Gastroenterology, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
Joan HeatheringtonDivision of Gastroenterology, Department of Medicine, University of Calgary, Calgary, Alberta, Canada.
Vipul JairathDivision of Gastroenterology, Department of Medicine, Schulich School of Medicine & Dentistry, Western University, London, Ontario, Canada.
Jennifer JonesDivision of Digestive Care & Endoscopy, Department of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada.
Paul MoayyediDepartment of Medicine, Farncombe Family Digestive Research Institute, McMaster University, Hamilton, Ontario, Canada.
Adam V WeizmanDivision of Gastroenterology, Department of Medicine, Mount Sinai Centre for Inflammatory Bowel Disease, University of Toronto, Toronto, Ontario, Canada.
Catherine DubéDivision of Gastroenterology, Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada.
Donald MacIntoshDivision of Digestive Care & Endoscopy, Department of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada.
Geoffrey C NguyenDivision of Gastroenterology, Department of Medicine, Mount Sinai Centre for Inflammatory Bowel Disease, University of Toronto, Toronto, Ontario, Canada.
Dalhousie University · CAUniversity of Toronto · CACrohn's and Colitis Canada · CAMcGill University Health Centre · CAMcMaster University · CAUniversity of British Columbia · CAUniversity of Calgary · CAUniversity of Ottawa · CAWestern University · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe Global Rating Scale (GRS) is a web-based self-assessment quality improvement tool used to identify gaps in health care, change the focus to patient-centred care and standardize care. There are four levels of achievement ranging from basic-(D) to excellent-(A) service delivery. The goal was to develop a GRS for inflammatory bowel disease (IBD) to improve the quality of care for patients on a system level.

methodsThe IBD GRS was developed through an iterative process and modeled upon the successful endoscopy GRS programs in the United Kingdom and Canada. Dimensions, items and statements were drafted based on expert opinions, patient-informed quality indicators and best available evidence, then reviewed and modified by a core committee. A working group of IBD and GRS experts voted in-person to establish consensus on the inclusion and quality of statements.

resultsTwo dimensions (Clinical Quality and Quality of Patient Experience), 10 items and 89 statements made up the IBD GRS. There was a 100% response rate for each of the 40 votes for statements in the IBD GRS. All statements within each level received a mean rating score between four (agree) and five (strongly agree). Revisions agreed upon during the voting process were incorporated into the IBD GRS. Group consensus was achieved on the inclusion of statements, and 10 items were selected as standards within the two dimensions.

conclusionsWe have developed the first IBD GRS with the aim of improving quality of care through ongoing evaluations and improvements by health care teams, focusing on patient-centred care.

Indexed as

Crohn’s diseaseGlobal rating scaleInflammatory bowel diseaseQuality improvementUlcerative colitis

Identifiers

PMID34169223
PMCPMC8218537
OpenAlexW2952560972

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.